6 Biotech Stocks Short Sellers Are Avoiding

:

All of the Biotech companies mentioned below have been boosted by short sellers covering their positions over the last month.

Average Weekly Returns:

Average 1-Week Return of All Stocks Mentioned Below: 2.38%

Average 1-Month Return of All Stocks Mentioned Below: 5.38%

Analysis of List Alpha:

Number of Stocks in This List Generating Excess Return vs. SP500 (Beta Adjusted Over Last Week): 3 out of 6 (50.0%)

Number of Stocks in This List Generating Excess Return vs. SP500 (Beta Adjusted Over Last Month): 2 out of 6 (33.33%)

Chart: Distribution of 1-Week Returns For All Stocks Mentioned Below

Chart: Distribution of 1-Month Returns For All Stocks Mentioned Below

1. Dendreon Corp. (DNDN): Engages in the discovery, development, and commercialization of therapeutics to enhance cancer treatment options for patients. Shares shorted currently at 45.68M vs. 47.16M shares shorted in the previous month (a decrease in short interest representing 1.01% of total float).

2. MannKind Corp. (MNKD): Focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer. Shares shorted currently at 25.51M vs. 27.11M shares shorted in the previous month (a decrease in short interest representing 1.27% of total float).

3. Cell Therapeutics, Inc. (CTIC): Engages in the development, acquisition, and commercialization of drugs for the treatment of cancer. Shares shorted currently at 1.91M vs. 2.39M shares shorted in the previous month (a decrease in short interest representing 1.37% of total float).

4. Threshold Pharmaceuticals Inc. (THLD): Engages in the discovery and development of drugs targeting the microenvironment of solid tumors for patients living with cancer. Shares shorted currently at 7.18M vs. 7.87M shares shorted in the previous month (a decrease in short interest representing 1.53% of total float).

5. Affymax, Inc. (AFFY): Engages in the development of drugs for the treatment of serious and life-threatening conditions. Shares shorted currently at 3.51M vs. 4.22M shares shorted in the previous month (a decrease in short interest representing 2.22% of total float).

6. Momenta Pharmaceuticals Inc. (MNTA): Momenta Pharmaceuticals, Inc., a biotechnology company, specializes in the in the characterization and process engineering of complex molecules. Shares shorted currently at 3.01M vs. 4.44M shares shorted in the previous month (a decrease in short interest representing 3.84% of total float).